ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,011.12
-0.22%
US Tech 100
16,880.80
-0.90%
Dow Jones
37,775.38
0.06%
Brent Oil
87.615
1.39%
Bitcoin
64,046.88
0.85%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zai Lab Ltd (ZLAB) Quote

Zai Lab Ltd

Zai Lab Ltd (ZLAB)

NASDAQ
14.22
0.50
(3.64%)
Closed April 19 4:00PM
Delayed by 15 minutes
14.22
0.00
(0.00%)
After Hours: 4:08PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
14.22
Bid
14.01
Ask
16.19
Volume
694,734
13.48 Day's Range 14.23
0.00 52 Week Range 0.00
Market Cap
-
Previous Close
13.72
Open
13.62
Last Trade
1041
@
14.22
(formt)
Last Trade Time
Financial Volume
$ 9,773,604
VWAP
14.0681
Average Volume (3m)
-
Shares Outstanding
-
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Zai Lab Ltd

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of th... Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.zailaboratory.com
Headquarters
George Town, Cym
Founded
1970
Zai Lab Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZLAB. The last closing price for Zai Lab was $13.72. Over the last year, Zai Lab shares have traded in a share price range of $ 0.00 to $ 0.00.

Zai Lab currently has 0 shares outstanding.

ZLAB Latest News

More News

Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024

- Company to Host Conference Call and Webcast on May 9, 2024, at 8:00 a.m. ET (8:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for...

April 15 2024
Business Wire

Zai Lab Statement on Executive Management Team’s Agreement on Share Activities

The Executive Officers of Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), Samantha Du, Josh Smiley, Rafael Amado, Harald Reinhart, Yajing Chen, F. Ty Edmondson, as well as Jonathan Wang, today...

April 11 2024
Business Wire

Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs

Poster sessions to highlight Phase 1 trials of internal oncology candidates ZL-1310, a next-generation antibody-drug conjugate for small cell lung cancer and other DLL3+ solid tumors, and...

April 02 2024
Business Wire

Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...

  Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with...

April 01 2024
Business Wire

Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive care compared to 11.3 months for patients treated...

March 27 2024
Business Wire

Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors

ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung cancer and other DLL3+ solid tumors Data will be shared in a poster presentation at the European...

March 13 2024
Business Wire

Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC)

- Findings will be shared in oral presentations at the 2024 Congress of the European Society of Gynaecological Oncology (ESGO) and the 2024 Society for Gynecologic Oncology (SGO) Annual Meeting...

March 06 2024
Business Wire

Zai Lab Announces Participation in March Investor Conference

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conference in March 2024: Leerink...

March 06 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AGBAAGBA Group Holding Ltd
$ 1.02
(155.00%)
122.88M
ISPCiSpecimen Inc
$ 0.437
(105.16%)
37.44M
TIRXTian Ruixiang Holdings Ltd
$ 0.7898
(62.93%)
58.67M
XPONExpion360 Inc
$ 3.12
(61.66%)
16.63M
BNTCBenitec Biopharma Limited
$ 6.99
(45.63%)
3.51M
WISAWiSA Technologies Inc
$ 5.89
(-36.32%)
16.09M
SPCBSuperCom Ltd
$ 0.24
(-33.31%)
8.57M
EDBLEdible Garden AG Inc
$ 4.52
(-32.13%)
698.17k
MRNOMurano Global Investments PLC
$ 7.22
(-31.24%)
123.91k
AILEiLearningEngines Holdings Inc
$ 7.11
(-28.90%)
53.08k
SINTSiNtx Technologies Inc
$ 0.0396
(6.17%)
438.98M
SQQQProShares UltraPro Short QQQ
$ 12.07
(1.77%)
172.66M
AGBAAGBA Group Holding Ltd
$ 1.02
(155.00%)
122.88M
GGEGreen Giant Inc
$ 0.0362
(23.76%)
96.91M
TSLATesla Inc
$ 149.93
(-3.55%)
96.1M

Discussion

View Full Feed
fuagf fuagf 5 minutes ago
Trump's jury intimidation BACKFIRES on him at trial

"Cohen suggested a month to get a jury, they got seven more quickly. OOps --
Live Updates: Two Jurors Are Dismissed as Selection Continues in Trump Trial"

[yt]rTCOeTxPLR4[/yt]
Brian Tyler Cohen
CaptHowdy CaptHowdy 10 minutes ago
Cool story, but I haven't taken a loss here. You were not here when I loaded the boat at sub penny PPS during the days of Mrs. Mars. I held just over 4M shares selling blocks as PPS rose to over 25 cents.

Next conspiracy theory.......?
RXMD
palaypu0406 palaypu0406 10 minutes ago
I have already stated, I will not be responding to you anything!!
Good Luck to all of your whimsical attempts,
ITUP
FMDK FMDK 12 minutes ago
Quite funny to constantly read BULLISH here while the stock loses more and more value from day to day. LOL
MVNT
palaypu0406 palaypu0406 12 minutes ago
And I dare request you Mr Steven to not delete this post for the allegations you have posted on me.
I have been on the post for over a few years now....
Whether I have conspired or conspiring or my conduct has been truthful or compromising, the shareholders here know well of me...
ITUP
bbotcs bbotcs 14 minutes ago
lj: It seems that Israel hitting Iran's oil fields might be on the table, if you believe what talking heads on cable TV say. It seems that Netanyahu doesn't care what the Biden Administration thinks, so it might happen.
newmedman newmedman 15 minutes ago
they are really cool. They make me wonder about our life on earth.. to me they are a living dinosaur and I'm fascinated by them. always have been. To me it's kind of special that I can actually hang out with them if I don't kill myself first..
stealofadeal stealofadeal 16 minutes ago
$MGON Joel Gardner isn’t listed but still runs the show. Complete scam for him to dump shares. SCAMMER
MGON
2H2 2H2 16 minutes ago
And once again the list of members of the SCO, guess who’s backing Iran. Yes we are knee deep in W3 unfortunately.

https://en.wikipedia.org/wiki/Shanghai_Cooperation_Organisation
SPY
bbotcs bbotcs 16 minutes ago
lj: Stocks that have bad earnings get hammered mercilessly in this market.
HighYieldStocks HighYieldStocks 18 minutes ago
Check out this article by The Extractor Magazine detailing our plans to drill a potential initial exploration well on PEL 93, targeting the Damara play in the Owambo Basin as early as the second half of 2025.

Read here: https://bit.ly/3vYXSS6
EEENF
bbotcs bbotcs 18 minutes ago
DD: If he fell asleep in court--so what? He does more in 1 day than Joe Biden does in a year. Your obsession with this is very, very sad. Typical of people who have Trump Derangement Syndrome. VERY hateful.
stealofadeal stealofadeal 19 minutes ago
$MGON Joel Gardner is a scammer who is running this company behind the scenes. He has a front guy as the CEO. SCAM
MGON
HighYieldStocks HighYieldStocks 19 minutes ago
QUARTERLY ACTIVITIES REPORT For the quarter ended 31 March 2024

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02796819-6A1203204
ASX
Alexulf Alexulf 20 minutes ago
Researchers have provided a price estimation on the share price of PlantX this year.
Friday again guys, let`s see if the stock moves today - check the link;
https://vegainvestors.com/news/analysts-report-for-plantx-reveals-increased-target-price-pltxfotc-us-vega-cn/ Good luck
VEGA
HighYieldStocks HighYieldStocks 20 minutes ago
https://www.petroleumnews.com/pntruncate/459893104.shtml
EEENF
HighYieldStocks HighYieldStocks 25 minutes ago
NEWS!!! FURTHER INFORMATION ON HICKORY-1 FLOW TEST RESULTS
ANNOUNCED 2 AND 15 APRIL 2024

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02797278-6A1203406
ASX
nowwhat2 nowwhat2 27 minutes ago
It go up and it go down.
They window. dressed the quarter so heavy with that ETF. I expected more consolidation through the holiday plus these extraordinary events. I guess it’s still too early …..
BTCUSD
doingfine doingfine 28 minutes ago
So, he’s no Ali G but more like a Bruno??
littlejohn littlejohn 30 minutes ago
U.S. needs to be forceful on Red Sea

shipping being restored now...

And inform Iran that any vessels that

target Any shipping vessels will then be

targeted to be destroyed...

And let Israel and Iran both know that
doingfine doingfine 30 minutes ago
You mean Biden….same thing I suppose.
a false profit a false profit 30 minutes ago
as far as i know , TLRY is in fact headquartered in Canada . do some due diligence , it will reward you eventually . BUT , yes ! the refusal of the Demoncratic party in the U.S.S.A. to do what they/them announced what they/them were going to do , which of course , as you , and 400,000,000 some odd "
TLRY

Your Recent History

NASDAQ
ZLAB
Zai Lab
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved